Search Login Register
Nevirapine
(Viramune)
Summary
Description:
A potent, non-nucleoside reverse transcriptase inhibitor used in combination with nucleoside analogues for treatment of HIV infection and AIDS.
Also Known As:
Viramune; BI-RG-587; Cahill May Roberts Brand of Nevirapine; Promeco Brand of Nevirapine; BI RG 587 Show All >>
Networked: 684
relevant articles (36 outcomes,
121 trials/studies)
for this Drug
Key Diseases for which Nevirapine is
Relevant
-
Infection
:
10 outcomes 21 studies in 120 results
-
HIV Infections (HIV Infection)
:
7 outcomes 15 studies in 111 results
-
Acquired Immunodeficiency Syndrome (AIDS)
:
6 outcomes 34 studies in 87 results
-
Tuberculosis (Tuberculoses)
:
5 outcomes 5 studies in 47 results
-
Exanthema (Rash)
:
2 outcomes 21 studies in 106 results
Show All >>
Drugs Related to Nevirapine
-
Zidovudine (Retrovir)
-
efavirenz (Sustiva)
-
Stavudine (Zerit)
-
Didanosine (Videx)
-
Carbon Monoxide
-
Rifampin (Rifampicin)
-
Lamivudine (3TC)
-
Ritonavir (Norvir)
-
RNA-Directed DNA Polymerase (Reverse Transcriptase)
-
Protease Inhibitors (Protease Inhibitor)
Show All >>
Therapies Related to Nevirapine
-
Highly Active Antiretroviral Therapy (HAART)
-
Cesarean Section (Caesarean Section)
-
Salvage Therapy
-
Art Therapy
-
Drug Therapy (Chemotherapy)
Show All >>
CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.